Search research articles
Contact Us
Filters
Showing results (11-20 of 703) with videos related to
Page
of 71
Sort By:
International Journal of Clinical and Experimental Medicine
|
December 3, 2015
Role of WNT1-inducible-signaling pathway protein 1 in etoposide resistance in lung adenocarcinoma A549 cells
Yunhua Xu, Shun Lu
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
December 17, 2013
Metformin inhibits esophagus cancer proliferation through upregulation of USP7
Yunhua Xu, Shun Lu
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 22, 2023
Third-Generation EGFR Tyrosine Kinase Inhibitor for Central Nervous System Metastases EGFR-Mutant NSCLC: Current Evidence and Future Perspectives
Ziming Li, Shun Lu
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 9, 2023
Who Should Receive the Chemotherapy-Free Combination of Nivolumab Plus Ipilimumab as the First-Line Treatment of Advanced Non-Small-Cell Lung Cancer?
Ziming Li, Shun Lu
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
October 12, 2013
[Research status on targeted therapy for squamous cell lung cancer]
Hong Yuan, Shun Lu
American Journal of Translational Research
|
January 26, 2016
Regulation of β-catenin-mediated esophageal cancer growth and invasion by miR-214
Yunhua Xu, Shun Lu
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
August 27, 2010
[Perioperative chemotherapy of stage III N2 non-small cell lung cancer.]
Shun Lu, Yongfeng Yu
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 26, 2022
Rethinking the Status of Chemotherapy Combined With the Addition of Cytotoxic T-Lymphocyte-Associated Antigen 4 Inhibition and Programmed Death 1 or Programmed Death-Ligand 1 Blockade
Shun Lu, Ziming Li
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 30, 2019
Rethinking Our Approach of Combining Novel Agents With Standard Chemotherapy in Small Cell Lung Cancer
Shun Lu, Ziming Li
The Lancet. Respiratory Medicine
|
November 1, 2024
First-line treatment for advanced NSCLC in older patients and those with poor performance status
Ziming Li, Shun Lu
Page
of 71
Search research articles
Search
Showing results (11-20 of 703) with videos related to
Sort By:
Page
of 71
International Journal of Clinical and Experimental Medicine
|
December 3, 2015
Role of WNT1-inducible-signaling pathway protein 1 in etoposide resistance in lung adenocarcinoma A549 cells
Yunhua Xu, Shun Lu
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
December 17, 2013
Metformin inhibits esophagus cancer proliferation through upregulation of USP7
Yunhua Xu, Shun Lu
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 22, 2023
Third-Generation EGFR Tyrosine Kinase Inhibitor for Central Nervous System Metastases EGFR-Mutant NSCLC: Current Evidence and Future Perspectives
Ziming Li, Shun Lu
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 9, 2023
Who Should Receive the Chemotherapy-Free Combination of Nivolumab Plus Ipilimumab as the First-Line Treatment of Advanced Non-Small-Cell Lung Cancer?
Ziming Li, Shun Lu
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
October 12, 2013
[Research status on targeted therapy for squamous cell lung cancer]
Hong Yuan, Shun Lu
American Journal of Translational Research
|
January 26, 2016
Regulation of β-catenin-mediated esophageal cancer growth and invasion by miR-214
Yunhua Xu, Shun Lu
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
August 27, 2010
[Perioperative chemotherapy of stage III N2 non-small cell lung cancer.]
Shun Lu, Yongfeng Yu
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 26, 2022
Rethinking the Status of Chemotherapy Combined With the Addition of Cytotoxic T-Lymphocyte-Associated Antigen 4 Inhibition and Programmed Death 1 or Programmed Death-Ligand 1 Blockade
Shun Lu, Ziming Li
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 30, 2019
Rethinking Our Approach of Combining Novel Agents With Standard Chemotherapy in Small Cell Lung Cancer
Shun Lu, Ziming Li
The Lancet. Respiratory Medicine
|
November 1, 2024
First-line treatment for advanced NSCLC in older patients and those with poor performance status
Ziming Li, Shun Lu
Page
of 71